VolumeAfter 2.5 hours of trading on Toronto only 100 share have traded. No one believes anything of significance is about to occur. The idea of an AA seems remote and a bit ridiculous. The company sends Look to represent them at a biotech conference and really his contribution seems minimal over the years he has occupied this position. This position should be using past infleunce to encourage new investment but he has failed miserably. Can't understand the b of d authorizing this. The cost benefit of a fireside chat should have been obvious and not done. The clock is ticking and they need to either sell or find a buyer before the end of November. A r/s will not be an option this time because that absolutely will be the nail in the coffin. As has been the case for years now, no one within the scientific community is buying what they are offering. I hope I am wrong but the past was the same and nothing has changed except perhaos the interest level is at an all time low.